|
A.S. Ametov
ADVANTAGES OF FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE (KOMBOGLYCE PROLONG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№5 / 2015
|
|
N.V. Zaitseva, M.Sh. Shamkhalova
COMBINATION THERAPY WITH GLIMEPIRIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. THE RESULTS OF OBSERVATIONAL STUDIES
|
№16 / 2014
|
|
N.A. Petunina , I.A. Kuzina
METFORMIN - A RELIABLE PARTNER IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
I.Yu.Demidova, V. V. Boeva
EARLY DIAGNOSIS AND TREATMENT OF IMPAIRED FASTING GLUCOSE REDUCES RATE OF ITS CONVERSION TO IMPAIRED GLUCOSE TOLERANCE AND TYPE 2 DIABETES MELLITUS
|
№10 / 2013
|
|
N.A. Petunina, L.V. Trukhina, E.I. Sinitsina, M.B. Antsiferov
Benefits Of Long-acting Metformin
|
№5 / 2013
|
|
E.E.Arinina, M.A.Rasheed, M. B. Antsiferov
Pharmacoeconomic Analysis Of Advantages Of Combined Incretin Therapy In Patients With Type 2 Diabetes Mellitus By The Example Of Vildagliptin
|
№5 / 2013
|
|
I.N. Zakharova, MD, Prof.; S.V. Yablochkova
Metabolic Syndrome In Children: A Modern View On The Problem
|
№1 / 2013
|
|
A.S. Ametov, MD, Professor; A.V. Braschenkova
Rational Pharmacotherapy Of Type 2 Diabetes Mellitus: Use Of Dpp-4 Inhibitor Saxagliptin And Metformin In Clinical Practice
|
№16 / 2012
|
|
M.B. Antsiferov
Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№7 / 2012
|
|
T.V. Nikonova
Sustained-release Metformin (glucophage Long) In The Management Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
Русский
